Kinepolis Group NV (KIN)

Overview

Neuronetics, Inc. is a pioneer in the medical technology industry, focusing on the development and marketing of innovative solutions for patients suffering from neurohealth disorders. Established in 2001 and based in Malvern, Pennsylvania, the company has made significant strides in offering advanced therapeutic options for individuals diagnosed with major depressive disorder, primarily in the United States and internationally. Neuronetics stands out for its dedication to non-invasive, office-based treatments that aim to improve the quality of life for patients struggling with mental health conditions without the need for systemic medications or invasive procedures.

Products and Services

• NeuroStar Advanced Therapy System

  This flagship product from Neuronetics represents a groundbreaking approach to treating adult patients with major depressive disorder. The NeuroStar Advanced Therapy System utilizes transcranial magnetic stimulation (TMS) technology to produce a pulsed, MRI-strength magnetic field. This field induces electrical currents in specific areas of the brain associated with mood regulation, thereby stimulating these regions to alleviate depressive symptoms. The system is designed for non-invasive and non-systemic treatment, making it an appealing option for patients seeking alternatives to traditional antidepressant medications or those who have not responded well to other therapies. Neuronetics markets this innovative therapy through a dedicated sales and customer support team, focusing on psychiatrists as the primary channel for distribution.